Volume 6, Issue 1 (Feb 2018)                   Res Mol Med (RMM) 2018, 6(1): 5-15 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Javdani H, Parsamanesh N. MicroRNA as Novel Strategies for Cancer Treatment . Res Mol Med (RMM) 2018; 6 (1) :5-15
URL: http://rmm.mazums.ac.ir/article-1-277-en.html
1- 1. Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran. 2. Molecular Medicine Department, Birjand Faculty of Medicine, Birjand University of Medical Sciences , Birjand, Iran
2- 1. Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran. 2. Molecular Medicine Department, Birjand Faculty of Medicine, Birjand University of Medical Sciences , Birjand, Iran , neginparsa.684@gmail.com
Abstract:   (3313 Views)

MicroRNAs (mirNAs) have garnered tremendous interest in cancer biology research in the recent decade. mirNAs are a group of short non-coding RNAs,20–24 nucleotides in length, thatare found in animals and plants.Theycan reduce the expression of genes involved in numerous vital cell processes. Recent evidences indicate a key role played by mirNAs in the initiation and development of human carcinogenesis. These function including: the regulation of oncogenes, tumor suppressor genes, and several tumor-associated genes to that of processes such as cell proliferation, apoptosis, and angiogenesis. Clinical trials aimed at improving mirNA profiling for clinical diagnosis and prognosis of different disorders are now underway. In this review, we have summarized the physiological role of mirNAs and theirdiagnostic and therapeutic
potential inclinical assessment.

Full-Text [PDF 682 kb]   (1441 Downloads)    
Type of Study: review | Subject: Molecular biology
Published: 2019/03/12

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Research in Molecular Medicine

Designed & Developed by : Yektaweb